Vera Therapeutics, Inc. (VERA): Total Assets
$734.73M
As of 2025-12-31
$532.98M
As of 2026-06-30
+77.5%
3-year compound annual growth
+68.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $734.73M | +12.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $655.68M | +273.5% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $175.55M | +33.6% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $131.44M | +56.9% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $83.75M | +53.5% | 2023-03-28, Balance as of period end |
| 2020-12-31 | $54.55M | n/a | 2022-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | 2025-12-31 | $734.73M | +12.1% |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | $738.36M | -2.9% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $726.16M | -11.8% |
| Summit Therapeutics Inc. (SMMT) | 2025-12-31 | $751.18M | +72.5% |
| Aurinia Pharmaceuticals Inc. (AUPH) | 2025-12-31 | $751.59M | +36.5% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $717.90M | -34.2% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $717.60M | -25.0% |
| Viking Therapeutics, Inc. (VKTX) | 2025-12-31 | $715.73M | -21.2% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $763.63M | +31.5% |
Compare VERA, KURA, SDGR, SMMT side by side · Screen every company in Pharmaceutical Preparations ↗